A Case of Thoracic Giant Cell Tumor of Bone and Discussion of Radiological Features and Current Management Practices

Overview

Journal Radiol Case Rep

Publisher Elsevier

Specialty Radiology

Date 2016 Sep 6

PMID 27594954

Citations 4

Authors

Deirdre Kelly

Sarah Mc Erlean

Danielle Byrne

Peter Mac Mahon

John Mc Caffrey

Affiliations

Soon will be listed here.

Abstract

Giant cell tumor of bone (GCTB) is a rare condition with distinct radiological features that aid diagnosis. We present the case of an adult female patient, with locally invasive GCTB and review important radiological and management principles. Specific radiological features include locally aggressive, lytic radiolucent lesions, which can demonstrate cortical thinning and expansile remodeling of bone and typically involve the epiphysis and metaphysis. Management is primarily surgical, and denosumab has a role in the advanced setting.

Citing Articles

L5 giant cell tumor in 28-year-old female.

Baskoro W, Pratama M, Fauziah E, Rusidi H, Kameswari B Surg Neurol Int. 2024; 15:436.

PMID: 39640347 PMC: 11618681. DOI: 10.25259/SNI_533_2024.

Giant cell tumor of the thoracic spine causing acute paraplegia-a case report.

Lucasti C, Patel D, Hawayek B, Maraschiello M, Kowalski J J Spine Surg. 2021; 7(2):208-213.

PMID: 34296034 PMC: 8261563. DOI: 10.21037/jss-20-652.

Changing care pathways and between-center practice variations in intensive care for traumatic brain injury across Europe: a CENTER-TBI analysis.

Huijben J, Wiegers E, Lingsma H, Citerio G, Maas A, Menon D Intensive Care Med. 2020; 46(5):995-1004.

PMID: 32100061 PMC: 7210239. DOI: 10.1007/s00134-020-05965-z.

Primary thoracic giant cell tumor of bone sensitive to steroids.

Yang H, Im G, Nielsen G, Kheterpal A, Schwab J Skeletal Radiol. 2018; 47(10):1431-1435.

PMID: 29502130 DOI: 10.1007/s00256-018-2911-y.

References

Arnold R, van Holsbeeck M, Mayer T, Mott M, Koch S . Best cases from the AFIP: Necrotic giant cell tumor of bone manifesting with pathologic fracture. Radiographics. 2011; 31(1):93-8. DOI: 10.1148/rg.311105048. View

Tse L, Wong K, Kumta S, Huang L, Chow T, Griffith J . Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone. 2007; 42(1):68-73. DOI: 10.1016/j.bone.2007.08.038. View

Wang C, Lou J, Liao J, Ding X, Du L, Lu Y . Recurrence in giant cell tumour of bone: imaging features and risk factors. Radiol Med. 2012; 118(3):456-64. DOI: 10.1007/s11547-012-0860-4. View

Campanacci M, Baldini N, Boriani S, Sudanese A . Giant-cell tumor of bone. J Bone Joint Surg Am. 1987; 69(1):106-14. View

Chakarun C, Forrester D, Gottsegen C, Patel D, White E, Matcuk Jr G . Giant cell tumor of bone: review, mimics, and new developments in treatment. Radiographics. 2013; 33(1):197-211. DOI: 10.1148/rg.331125089. View

Manaster B, Doyle A . Giant cell tumors of bone. Radiol Clin North Am. 1993; 31(2):299-323. View

Lau Y, Sabokbar A, Gibbons C, Giele H, Athanasou N . Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum Pathol. 2005; 36(9):945-54. DOI: 10.1016/j.humpath.2005.07.005. View

Resnik C, Steffe J, Wang S . Case report 353: Giant cell tumor of distal end of the femur, containing a fluid level as demonstrated by computed tomography. Skeletal Radiol. 1986; 15(2):175-7. DOI: 10.1007/BF00350215. View

Xu W, Li X, Huang W, Wang Y, Han S, Chen S . Factors affecting prognosis of patients with giant cell tumors of the mobile spine: retrospective analysis of 102 patients in a single center. Ann Surg Oncol. 2012; 20(3):804-10. DOI: 10.1245/s10434-012-2707-6. View

10.

Kaban L, Troulis M, Ebb D, August M, Hornicek F, Dodson T . Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. J Oral Maxillofac Surg. 2002; 60(10):1103-11; discussion 1111-3. DOI: 10.1053/joms.2002.34975. View

11.

Campanacci M, Giunti A, Olmi R . [Metaphyseal and diaphyseal localization of giant cell tumors]. Chir Organi Mov. 1975; 62(1):29-34. View

12.

Carrasco C, Murray J . Giant cell tumors. Orthop Clin North Am. 1989; 20(3):395-405. View

13.

Balke M, Campanacci L, Gebert C, Picci P, Gibbons M, Taylor R . Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone. BMC Cancer. 2010; 10:462. PMC: 2940802. DOI: 10.1186/1471-2407-10-462. View

14.

Van der Heijden L, Dijkstra P, van de Sande M, Kroep J, Nout R, van Rijswijk C . The clinical approach toward giant cell tumor of bone. Oncologist. 2014; 19(5):550-61. PMC: 4012970. DOI: 10.1634/theoncologist.2013-0432. View

15.

Morgan T, Atkins G, Trivett M, Johnson S, Kansara M, Schlicht S . Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB. Am J Pathol. 2005; 167(1):117-28. PMC: 1603441. DOI: 10.1016/s0002-9440(10)62959-8. View

16.

Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay J . Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol. 2010; 11(3):275-80. DOI: 10.1016/S1470-2045(10)70010-3. View

17.

Kransdorf M, Sweet D . Aneurysmal bone cyst: concept, controversy, clinical presentation, and imaging. AJR Am J Roentgenol. 1995; 164(3):573-80. DOI: 10.2214/ajr.164.3.7863874. View

18.

Kaplan P, Murphey M, Greenway G, Resnick D, Sartoris D, Harms S . Fluid-fluid levels in giant cell tumors of bone: report of two cases. J Comput Tomogr. 1987; 11(2):151-5. DOI: 10.1016/0149-936x(87)90008-7. View

19.

Turcotte R . Giant cell tumor of bone. Orthop Clin North Am. 2005; 37(1):35-51. DOI: 10.1016/j.ocl.2005.08.005. View

20.

Aoki J, Tanikawa H, Ishii K, Seo G, Karakida O, Sone S . MR findings indicative of hemosiderin in giant-cell tumor of bone: frequency, cause, and diagnostic significance. AJR Am J Roentgenol. 1996; 166(1):145-8. DOI: 10.2214/ajr.166.1.8571864. View